Papilocare®: Effects on Regression of Histologically Confirmed Cervical Intraepithelial Lesions 1 and Tolerance

Clinical trial NCT04624568 · COMPLETED

Trial details

NCT number: NCT04624568
Sponsor: Centre Hospitalier Régional d'Orléans
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Squamous Intraepithelial Lesions of the Cervix Human Papilloma Virus Infection Cervix Lesion

Start date: 2020-11-17
Primary completion: 2023-05-17
Enrollment: 81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.